Non-Alcoholic Steatohepatitis (NASH) Drugs Report

By www.marketgrowthrate.com

Report Details

Report Name

Global Non-Alcoholic Steatohepatitis (NASH) Drugs Market Insights, Forecast To 2031 Story

Pages

114

Price

$ 4900

Features

Non-Alcoholic Steatohepatitis (NASH) Drugs Report report is categorised based on following features:

1. Global Market Players

2. Geopolitical regions

3. Consumer Insights

4. Technological advancement

5. Historic and Future Analysis of the Market

Companies Covered

              AstraZeneca
Conatus Pharmaceuticals
Enzo Biochem
Galmed Pharmaceuticals
Genfit
Gilead
Horizon Pharma
Immuron
Intercept Pharmaceuticals
Novo Nordisk